A detailed history of Natixis transactions in Vericel Corp stock. As of the latest transaction made, Natixis holds 31,047 shares of VCEL stock, worth $1.54 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
31,047
Holding current value
$1.54 Million
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$40.05 - $59.11 $1.24 Million - $1.84 Million
31,047 New
31,047 $1.7 Million
Q4 2022

Feb 13, 2023

BUY
$17.65 - $27.37 $1.81 Million - $2.8 Million
102,300 New
102,300 $2.69 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.34B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.